MedTrace Logo

Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy

NCT00897299 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2017-05-17

No results posted yet for this study

Summary

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict whether cancer will come back after treatment.

PURPOSE: This laboratory study is identifying genes that may help predict recurrence in women with breast cancer treated with chemotherapy.

Conditions

Interventions

GENETIC

microarray analysis

GENETIC

protein expression analysis

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Eastern Cooperative Oncology Group

    lead NETWORK

Principal Investigators

  • Joseph A. Sparano, MD · Albert Einstein College of Medicine

  • Lori J. Goldstein, MD · Fox Chase Cancer Center

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-07
Primary Completion
2005-10-08
Completion
2005-10-08

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897299 on ClinicalTrials.gov